Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rusconi

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Neuropsychologia|January 1, 1995
Improvement of left visuo-spatial hemineglect by left-sided transcutaneous electrical stimulationG Vallar, M L Rusconi, S Barozzi, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1996
Italian experience with AutoCapture in conjunction with a membrane lead. Pacesetter Automatic Control of Energy and Membrane Automatic Threshold Evaluation (Pacemate) Study GroupS Sermasi, M Marconi, L Libero, et al.
Il Farmaco; Edizione Scientifica|November 1, 1985
Bicyclic compounds with potential antiulcer and/or antisecretory activity. I. 4,5,6,7-TetrahydrobenzimidazolesU Scarponi, R Cimaschi, L Rusconi, et al.
Neurobiology of Disease|February 8, 2020
The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivoL Trovò, C Fuchs, R De Rosa, et al.
Biochemistry|March 8, 2000
Activation of Zap-70 tyrosine kinase due to a structural rearrangement induced by tyrosine phosphorylation and/or ITAM bindingC Visco, G Magistrelli, R Bosotti, et al.
Pharmacological Research Communications|August 1, 1987
Behavioural and biochemical studies on 6-methylamino-4,5,6,7-tetrahydrobenzothiazole (14.839JL), a new potent dopaminergic agonistF Ponzio, S Algeri, S Garattini, et al.
Neuropharmacology|December 4, 2019
Pregnenolone and pregnenolone-methyl-ether rescue neuronal defects caused by dysfunctional CLIP170 in a neuronal model of CDKL5 Deficiency DisorderI Barbiero, D Peroni, P Siniscalchi, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 1, 1991
Bombesin receptor antagonists. 2. Analogues based on substance P antagonistsL Rusconi, R de Castiglione, L Gozzini, et al.
Neurocase|June 1, 2021
Different types of abstract concepts: evidence from two neurodegenerative patientsE Catricalà, F Conca, V M Borsa, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Neuropsychologia|January 1, 1995
Improvement of left visuo-spatial hemineglect by left-sided transcutaneous electrical stimulationG Vallar, M L Rusconi, S Barozzi, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1996
Italian experience with AutoCapture in conjunction with a membrane lead. Pacesetter Automatic Control of Energy and Membrane Automatic Threshold Evaluation (Pacemate) Study GroupS Sermasi, M Marconi, L Libero, et al.
Il Farmaco; Edizione Scientifica|November 1, 1985
Bicyclic compounds with potential antiulcer and/or antisecretory activity. I. 4,5,6,7-TetrahydrobenzimidazolesU Scarponi, R Cimaschi, L Rusconi, et al.
Neurobiology of Disease|February 8, 2020
The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivoL Trovò, C Fuchs, R De Rosa, et al.
Biochemistry|March 8, 2000
Activation of Zap-70 tyrosine kinase due to a structural rearrangement induced by tyrosine phosphorylation and/or ITAM bindingC Visco, G Magistrelli, R Bosotti, et al.
Pharmacological Research Communications|August 1, 1987
Behavioural and biochemical studies on 6-methylamino-4,5,6,7-tetrahydrobenzothiazole (14.839JL), a new potent dopaminergic agonistF Ponzio, S Algeri, S Garattini, et al.
Neuropharmacology|December 4, 2019
Pregnenolone and pregnenolone-methyl-ether rescue neuronal defects caused by dysfunctional CLIP170 in a neuronal model of CDKL5 Deficiency DisorderI Barbiero, D Peroni, P Siniscalchi, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 1, 1991
Bombesin receptor antagonists. 2. Analogues based on substance P antagonistsL Rusconi, R de Castiglione, L Gozzini, et al.
Neurocase|June 1, 2021
Different types of abstract concepts: evidence from two neurodegenerative patientsE Catricalà, F Conca, V M Borsa, et al.
Pageof 6